← Back to Search

Shared Decision Making Aid for Thyroid Nodule Evaluation

N/A
Waitlist Available
Led By Naykky Singh Ospina
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Patients with hyperthyroidism
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 months of follow up
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve communication between patients and clinicians about thyroid cancer diagnosis and treatment.

Who is the study for?
This trial is for adults over 18 years old who are getting checked for a thyroid nodule. It's not for those with an overactive thyroid, anyone who's had a biopsy on the nodule before, pregnant individuals, or prisoners.
What is being tested?
The study tests if using an electronic aid during doctor visits helps in making decisions together about diagnosing thyroid cancer. It updates and evaluates a tool meant to assist patient-clinician collaboration.
What are the potential side effects?
Since this trial involves counseling rather than medication or invasive procedures, there are no direct medical side effects. However, participants may experience stress or anxiety related to decision-making.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have an overactive thyroid.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 6 months of follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 6 months of follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of eligible patients for feasibility

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Counseling using the electronic conversation aid
Group II: Control GroupActive Control1 Intervention
Routine counseling only
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Counseling using the electronic conversation aid
2022
N/A
~160

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,409 Previous Clinical Trials
767,133 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,490 Total Patients Enrolled
Naykky Singh OspinaPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
66 Total Patients Enrolled

Media Library

Counseling by Routine Care Clinical Trial Eligibility Overview. Trial Name: NCT04463719 — N/A
Thyroid Cancer Research Study Groups: Control Group, Intervention group
~23 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top